about
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia ATowards personalised therapy for von Willebrand disease: a future role for recombinant productsHuman plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety dataEstablishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity.von Willebrand disease and platelet disorders.Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.Type 2M von Willebrand disease - more often misidentified than correctly identified.Von Willebrand disease in the emergency department.Rare forms of von Willebrand disease
P2860
Q26738507-99A06AA7-9645-409E-988F-6DE04618F797Q26748376-F73E70BE-63E2-44D0-807C-F2846C4B4E8CQ26750402-84DA4A6C-1A08-407E-AF0B-B99076D9271AQ36742828-EA2CD46F-ACCB-4A6E-B6BC-6EA94F81A459Q38206854-8A998460-CFA4-4370-93E2-4E492FA8128FQ38900471-3FA78700-FF0B-432F-8134-FB2CF1E051FDQ39876587-8CC446AD-0A1E-4875-933E-43FAEAB84AA1Q40329972-FE11D17B-6703-4365-A68D-0E361517B955Q57300553-7424A029-3D28-4C08-8B17-8B80E3D95132
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biological therapies for von Willebrand disease.
@en
Biological therapies for von Willebrand disease.
@nl
type
label
Biological therapies for von Willebrand disease.
@en
Biological therapies for von Willebrand disease.
@nl
prefLabel
Biological therapies for von Willebrand disease.
@en
Biological therapies for von Willebrand disease.
@nl
P2860
P50
P1476
Biological therapies for von Willebrand disease.
@en
P2860
P304
P356
10.1517/14712598.2012.667398
P407
P577
2012-03-20T00:00:00Z